Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Alemtuzumab
Fludarabine
+5 more
Locations
1
United States
Johns Hopkins University
Baltimore, Maryland, United States
Start Date
February 12, 2020
Primary Completion Date
December 31, 2027
Completion Date
December 31, 2028
Last Updated
November 28, 2025
NCT06090669
NCT05012111
NCT06817590
NCT03579875
NCT03128996
NCT03266627
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions